Pharmaceuticals
Speculative Inovio Pharmaceuticals Could Be a Home Run for Some Investors
This biotech is one of two companies in human trials for a vaccine for Covid-19.
Agilent Technologies Could Regain Its Former Peak
CEO McMullen said it's not a matter of if they'll have a vaccine, but when.
This Dividend Aristocrat Is the 'REIT' Choice Right Now
Realty Income isn't the highest yielding REIT around, but it offers sustainable dividends, and here's why.
Gilead Surges on Remdesivir Report: How to Play the Stock Now
We have a new price target for GILD.
Moderna Is Soaring on Funding News so It's Back to the Charts
Let's take a look at the charts and indicators.
5 Ways to Invest in Testing, Vaccines and Clinical Trials
These companies have the potential to help in battling the Covid-19 pandemic.
GlaxoSmithKline Charts Prescribe Positive Outlook as It Chases Covid-19 Vaccine
The drugmaker that is partnering with Sanofi to develop a vaccine has seen its shares push higher after declining to a low in late March.
Jim Cramer: Don't Mistake the Rally for Cheering
There is no joy in stockville -- instead we have big companies with stocks rising. Here's why that is and what you need to understand about the rally amid the crisis.
AstraZeneca Could Pause a While Before Challenging the Old Highs
Let's review the charts and indicators.
Eli Lilly Surges to a New High and a New Price Target Opens Up
An inspiring performance.